AlphaCrest Capital Management’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-7,887
Closed -$686K 800
2022
Q3
$686K Buy
7,887
+5,129
+186% +$539K 0.04% 822
2022
Q2
$314K Sell
2,758
-1,824
-40% -$209K 0.02% 1107
2022
Q1
$593K Sell
4,582
-907
-17% -$131K 0.03% 816
2021
Q4
$990K Sell
5,489
-11,694
-68% -$2.03M 0.04% 794
2021
Q3
$2.55M Buy
17,183
+12,268
+250% +$1.88M 0.13% 199
2021
Q2
$744K Buy
4,915
+2,408
+96% +$335K 0.03% 790
2021
Q1
$326K Buy
+2,507
New +$322K 0.02% 982
2020
Q2
Sell
-13,221
Closed -$867K 1053
2020
Q1
$867K Sell
13,221
-3,277
-20% -$261K 0.11% 328
2019
Q4
$1.35M Buy
+16,498
New +$1.27M 0.11% 222
2019
Q3
Sell
-6,300
Closed -$542K 1310
2019
Q2
$542K Sell
6,300
-4,200
-40% -$341K 0.05% 670
2019
Q1
$849K Buy
+10,500
New +$786K 0.13% 252

Other funds holding OMCL

AlphaCrest Capital Management's OMCL Position: Q4 2022 in Review

AlphaCrest Capital Management sold out of Omnicell (OMCL) in Q4 2022, closing a stake of 7,887 shares — an estimated $686K sold.

AlphaCrest Capital Management first reported a position in OMCL in Q1 2019 and held it in 11 quarters. The position peaked at $2.55M in Q3 2021. 329 funds tracked by Wall St. Rank hold OMCL as of Q4 2022.

  • AlphaCrest Capital Management reported no remaining Omnicell position as of Q4 2022 after selling out during the quarter.
  • AlphaCrest Capital Management sold 7,887 Omnicell shares in Q4 2022, an estimated $686K.
  • AlphaCrest Capital Management first reported a position in Omnicell in Q1 2019 and held it in 11 quarters.
  • AlphaCrest Capital Management's Omnicell position peaked at $2.55M in Q3 2021.
  • 329 funds tracked by Wall St. Rank held Omnicell as of Q4 2022.

Based on AlphaCrest Capital Management's 13F filing for Q4 2022.